Following encouraging trial findings , retatrutide, a innovative peptide therapy for addressing non-insulin dependent hyperglycemia , has obtained regulatory approval from the Drug and Regulatory Agency ( https://shopretatrutidepeptide.com/category/retatrutide-peptide/